Gene · 3623
Papers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,777
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug resistance in patients with tuberculosis: a study from a tertiary care center in northern India. | Monaldi Arch Chest Dis | 2026 | 42788205 | PubTator, text mining | PubMed |
| Comprehensive genome-based characterization and pan-genome analysis of Bacillus paranthracis SM02 isolated from a fermented food ecosystem. | Funct Integr Genomics | 2026 | 42776301 | PubTator, text mining | PubMed |
| Exploration of novel indolo[2,3-b]quinoxaline hybrids as InhA inhibitors: A multi-disciplinary approach involving synthesis, antimycobacterial evaluation and computational studies. | Eur J Med Chem | 2026 | 42767000 | PubTator, text mining | PubMed |
| Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole-Based Hydrazide Derivatives as Potential Anti-Tuberculosis Agents. | Chem Biol Drug Des | 2026 | 42760852 | PubTator, text mining | PubMed |
| Multi-Omics Analysis of the Effects of INHA and FNDC1 on Clutch Length in Zi Geese. | Int J Mol Sci | 2026 | 42589455 | PubTator, text mining | PubMed |
| Genotypic Characterization of Drug Resistance-associated Mutations in Mycobacterium tuberculosis Using Line Probe Assays in Central India. | Int J Mycobacteriol | 2026 | 42378606 | PubTator, text mining | PubMed |
| Identification and functional validation of P4HA1 and INHA as hypoxia-responsive biomarkers in preeclampsia. | Placenta | 2026 | 42302511 | PubTator, text mining | PubMed |
| Research overview-2025: integrating scientific progress to accelerate global tuberculosis elimination. | Front Tuberc | 2026 | 42267172 | PubTator, text mining | PubMed |
| Influence of Diabetes Mellitus on the Development of Multidrug-Resistant Tuberculosis (MDR-TB) in Relation With Genetic Mutations of M. tuberculosis Isolates in Ethiopia. | Can J Infect Dis Med Microbiol | 2026 | 42255943 | PubTator, text mining | PubMed |
| Water-Soluble Inclusion Complexation of Naphthyl-Containing Thiosemicarbazides and Thioureas with β-Cyclodextrin. | Molecules | 2026 | 42075968 | PubTator, text mining | PubMed |
| Predictive Analysis of Drug-Resistant Tuberculosis: Integrating Molecular Markers, Clinical Governance, and Community-Engaged Education in Rural South Africa. | Diseases | 2026 | 42041624 | PubTator, text mining | PubMed |
| Association of katG, inhA, and AhpC Mutations with Isoniazid Resistance of Mycobacterium tuberculosis in Pulmonary Tuberculosis Patients from Nanjing, China. | Microb Drug Resist | 2026 | 42037600 | PubTator, text mining | PubMed |
| Evaluation of antimycobacterial, antibacterial, and anticancer activities of new nodulisporacid derivatives isolated from endophytic fungus Hypoxylon pulicicidum using in silico studies. | Nat Prod Res | 2026 | 41985169 | PubTator, text mining | PubMed |
| Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosis. | Nat Commun | 2026 | 41946736 | PubTator, text mining | PubMed |
| Zoonotic Tuberculosis as a One Health Challenge: Global Evidence, Transmission Dynamics, and Policy Gaps in Indonesia. | Vet Sci | 2026 | 41893654 | PubTator, text mining | PubMed |
| Non-invasive environmental DNA sampling reveals tuberculosis risks at the human - Great Ape Interface in Africa. | Emerg Microbes Infect | 2026 | 41869690 | PubTator, text mining | PubMed |
| Correction to "Designing Novel InhA Inhibitors for Antituberculosis Agents Using ab Initio Fragment Molecular Orbital Calculations". | ACS Omega | 2026 | 41835612 | PubTator, text mining | PubMed |
| Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa. | ERJ Open Res | 2026 | 41809859 | PubTator, text mining | PubMed |
| Spinal cord injury-induced overflow incontinence reshapes the activin-follistatin-inhibin axis in mouse bladder and kidney. | Front Mol Biosci | 2026 | 41788624 | PubTator, text mining | PubMed |
| Investigation of Gene Regions Responsible for Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis Complex Resistant to at Least Two First-Line Anti-Tuberculosis Drugs. | Pathogens | 2026 | 41754474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3623/papers